1. Medical biotechnology is our topic.
Picture: ©vfa/Martin Joppen
vfa bio represents the biotech interests within the German Association of Research-Based Pharmaceutical Companies (vfa). vfa campaigns for the interests of 42 worldwide leading pharmaceutical companies in the fields of health, research and economy. vfa bio seeks to exploit the therapeutic and economic potential of biotechnology to make Germany the leading biotech location in Europe.
Medical biotechnology is our topic.
Consequently, we primarily deal with
Medical progress provided by biopharmaceuticals – relevance, benefit and value for patients, physicians and society as a whole
Access to biopharmaceuticals for patients
Business location Germany and regulatory and economic framework for research, development and production of biopharmaceuticals
Quality-assured use of biopharmaceuticals – original products and biosimilars
Orphan Drugs
Advanced therapies such as gene and cell therapies and tissue engineering products

2. state of the art data and facts in the field of medical biotechnology
vfa bio provides
state of the art data and facts in the field of medical biotechnology
annual report about the situation of medical biotechnology in Germany
position papers addressing relevant topics in medical biotechnology
strategic recommendations
workshops, roundtables and discussion forums
contact point for politicians, press and the public
platform for the exchange of information
forum for cooperations
nomination of contact partners for various fields
opportunities for networking between member firms
advantages of a full range association with full-time top experts in communication, distribution and future projects, legal and international affairs, market and reimbursement as well as research, development and innovation
vfa bio has 30 member companies.
Kontakt:
Dr. Siegfried Throm Dr. Sabine Sydow Dr. Rolf Hömke
Geschäftsführer vfa bio Leiterin vfa bio Wissenschaftspresse
Telefon Telefon Telefon